Impact Partnership Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Impact Partnership Wealth's PFE Position: Q1 2026 in Review
Impact Partnership Wealth reduced its Pfizer (PFE) stake by 66% in Q1 2026, selling an estimated $544K and leaving 10,400 shares worth $292K. The position accounts for 0.04% of the portfolio, ranked #278.
Impact Partnership Wealth first reported a position in PFE in Q2 2023 and has held it in 7 quarters since. The position peaked at $767K in Q4 2025. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Impact Partnership Wealth held 10,400 shares of Pfizer worth $292K as of Q1 2026.
- Impact Partnership Wealth sold 20,422 Pfizer shares in Q1 2026, an estimated $544K.
- Pfizer made up 0.04% of Impact Partnership Wealth's portfolio in Q1 2026, its #278 holding.
- Impact Partnership Wealth first reported a position in Pfizer in Q2 2023 and has held it in 7 quarters since.
- Impact Partnership Wealth's Pfizer position peaked at $767K in Q4 2025.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.